Kiniksa Pharmaceuticals Ltd (KNSA) valuation · rev $677.6M
Kiniksa Pharmaceuticals Ltd (KNSA) rev $677.6M.
| Metric | Value |
|---|---|
| Market cap | $3.73B |
| Revenue | $677.6M |
| P/S | 5.5 |
KNSA valuation FAQ
What is KNSA's market cap?
Kiniksa Pharmaceuticals Ltd (KNSA) market cap is $3.73B on the latest cached fundamentals snapshot.
What is KNSA's latest revenue?
Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue was $677.6M. Statements: https://lician.com/financials/knsa
What is KNSA's price-to-sales ratio?
Kiniksa Pharmaceuticals Ltd (KNSA) price-to-sales (P/S) is 5.5, cached market cap $3.73B divided by revenue $677.6M.
How many KNSA valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Kiniksa Pharmaceuticals Ltd (KNSA): Market cap, Revenue, and P/S.
Where is KNSA valuation listed?
Cached valuation multiples for Kiniksa Pharmaceuticals Ltd (KNSA) are listed at https://lician.com/valuation/knsa.
Not investment advice. Cached rows, not a live tape.